Foot-and-Mouth disease vaccine factory now owned by Intervet

Both parties have agreed not to disclose financial details. As of July 4, 2006 Intervet, internationally market leader in Animal Health vaccines, is responsible for managing the FMD factory. The site will become Intervet’s international competence centre for FMD vaccine production, development and research and will serve the needs from the markets for safe and efficacious FMD vaccines.

In addition to this, the factory will also engage in antigen banks, which can, under governmental contracts, guarantee emergency supply of vaccines. By acquiring the Cologne factory Intervet substantially strengthens its worldwide position in the field of Foot-and-Mouth disease vaccines.

More of the latest Pig Industry News

•   Uncertainities in Tackling GHG Emissions Accepted
•   Hans Enters Voluntary Administration
•   Milk Crisis Spills Out on All Food Sectors
•   Bavarian Farm Provides Feeding for 750 Breeding Sows
•   EU Pig Prices: Lateral Movement in Markets
•   Pork Commentary: Darkest Before the Dawn
•   TOPIGS Canada Purchases Maple Leaf Agri-Farms
•   New PRRS Virus, Possible Vaccine Failures Reported
•   Canada to Consult WTO on COOL Regulations
•   Producers Burdened with New Disposal Cost